A Phase I trial of ROR gamma inverse agonist

Trial Profile

A Phase I trial of ROR gamma inverse agonist

Phase of Trial: Phase I

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs ROR-gamma-inverse-agonists-Aurigene (Primary)
  • Indications Autoimmune disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Apr 2018 New trial record
    • 11 Apr 2018 Aurigene has filed an IND for the RORg program for autoimmune diseases and expects to initiate Phase I trial by Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top